- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid biomarkers in Parkinson disease
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 9, Issue 3, Pages 131-140
Publisher
Springer Nature
Online
2013-02-19
DOI
10.1038/nrneurol.2013.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid α-Synuclein Does Not Discriminate Between Dementia Disorders
- (2017) Petra E. Spies et al. JOURNAL OF ALZHEIMERS DISEASE
- Neprilysin Activity in Cerebrospinal Fluid is Associated with Dementia and Amyloid-β42 Levels in Lewy Body Disease
- (2017) Walter Maetzler et al. JOURNAL OF ALZHEIMERS DISEASE
- Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress
- (2014) Ruben K. Dagda et al. Autophagy
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia
- (2012) Stefan Lehnert et al. EXPERIMENTAL NEUROLOGY
- α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, andEscherichia coliExists Predominantly as Disordered Monomer
- (2012) Bruno Fauvet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Biochemical premotor biomarkers for Parkinson's disease
- (2012) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
- (2012) Paola Picotti et al. NATURE METHODS
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
- (2011) Fuyuki Tateno et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
- (2011) Yu Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Preclinical Biomarkers of Parkinson Disease
- (2011) Yuncheng Wu et al. ARCHIVES OF NEUROLOGY
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- CSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease
- (2011) Michael R. Sierks et al. Integrative Biology
- Changing Concepts of Alzheimer Disease
- (2011) Guy M. McKhann JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF biomarkers in different phenotypes of Parkinson disease
- (2011) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Induction of Intracellular Tau Aggregation Is Promoted by -Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of Tau
- (2011) E. A. Waxman et al. JOURNAL OF NEUROSCIENCE
- Amyloid-β and τ biomarkers in Parkinson's disease–dementia
- (2011) Mariateresa Buongiorno et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pathological roles of α-synuclein in neurological disorders
- (2011) Kostas Vekrellis et al. LANCET NEUROLOGY
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond
- (2011) Tamar Shachar et al. MOVEMENT DISORDERS
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
- (2011) Tim Bartels et al. NATURE
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
- (2011) Min Shi et al. NEUROBIOLOGY OF AGING
- Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice
- (2011) Alessandro Tozzi et al. NEUROBIOLOGY OF AGING
- CSF α-synuclein does not differentiate between parkinsonian disorders
- (2011) M.B. Aerts et al. NEUROBIOLOGY OF AGING
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson’s Disease
- (2011) Guanghua Wu et al. NEUROCHEMICAL RESEARCH
- Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- (2011) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- A soluble -synuclein construct forms a dynamic tetramer
- (2011) W. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Exploring the link between glucocerebrosidase mutations and parkinsonism
- (2011) Wendy Westbroek et al. TRENDS IN MOLECULAR MEDICINE
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
- (2011) Randall J Bateman et al. Alzheimers Research & Therapy
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- Problems associated with fluid biomarkers for Parkinson’s disease
- (2010) Jakob Nyhlén et al. Biomarkers in Medicine
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders
- (2010) Arash Velayati et al. Current Neurology and Neuroscience Reports
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The risk of Parkinson’s disease in type 1 Gaucher disease
- (2010) Gilberto Bultron et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
- (2010) P. Chérin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Synergistic Interactions between A , Tau, and -Synuclein: Acceleration of Neuropathology and Cognitive Decline
- (2010) L. K. Clinton et al. JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Glucocerebrosidase Gene L444P mutation is a risk factor for Parkinson's disease in Chinese population
- (2010) Qi-Ying Sun et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
- (2010) Karin D. van Dijk et al. NEUROBIOLOGY OF DISEASE
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies
- (2009) K. E. Paleologou et al. BRAIN
- The epidemiology of dementia associated with Parkinson disease
- (2009) Dag Aarsland et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
- (2009) L. Parnetti et al. NEUROBIOLOGY OF DISEASE
- In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
- (2009) M. A. Burack et al. NEUROLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
- (2008) Moeko Noguchi-Shinohara et al. BRAIN RESEARCH
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- (2008) Brit Mollenhauer et al. EXPERIMENTAL NEUROLOGY
- Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
- (2008) Tereza Vogiatzi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease
- (2008) Guanghua Wu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Phenotype, diagnosis, and treatment of Gaucher's disease
- (2008) Gregory A Grabowski LANCET
- Unknown
- (2008) G Irvine et al. MOLECULAR MEDICINE
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia
- (2008) Kurt A. Jellinger Neurodegenerative Diseases
- Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
- (2008) D. Aarsland et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy
- (2007) Elvira V. De Marco et al. MOVEMENT DISORDERS
- [11C]PIB binding in Parkinson's disease dementia
- (2007) Walter Maetzler et al. NEUROIMAGE
- Association between Parkinson's disease and glucocerebrosidase mutations in Brazil
- (2007) Mariana Spitz et al. PARKINSONISM & RELATED DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started